Thermo Fisher Scientific

Nalgene
Waltham, Massachusetts
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Danger
High Risk

Summary:

Thermo Fisher is High Risk. The company yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Thermo Fisher embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach fails to safeguard free exercise, free speech, and free enterprise.

View Full Corporate Bias Ratings Report

Board Bias

Expand Summary

CEO of Thermo Fisher Scientific

Marc N. Casper

Marc N. Casper

Summary:

Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Marc N. Casper and Marc N. Casper serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $829,907 to Republican causes and $421,611 to Democratic causes. Under their tenure, Thermo Fisher Scientific currently holds a 'High Risk' risk rating.

View Full Board Bias Report

Political Contributions of Leadership:

$829,907

$421,611

Republican

Democrat

China Risk Database

Expand Summary

Number of Facilities: 55

Total Export Dollars: $9,601,134

View Full China Report

Total Estimated Sanctions (3-year Avg.)

$831,946,997

Average Annual Revenue

Global

$33,830,333,333

China Revenue

8.96%

$3,031,333,333

Annual Average of Total Assets

Global

$74,146,000,000

China Assets

8.98%

$6,659,960,462

Generate Reports
Clear
Toast